RICHARD M. LEVIN, M.D., F.A.C.S.

Chesapeake Urology Associates, P.A.
8322 Bellona Avenue, Suite 202
Towson, MD 21204
410-825-6310 - Office
410-825-6320 - Fax

                                                American Board of Urology - February 1997

                                                Diplomat, National Board of Medical Examiners - 1990

                                                State of Maryland - Current

                                                State of Colorado - Current

            1989                            Emory University School of Medicine

                                                Doctor of Medicine

            1985                            University of Pennsylvania

                                                B.S. in Biology

            July 1991-1995           University of Colorado Health Services Center

                                                Denver, Colorado

                                                Urology

            July 1995                     Female Incontinence and Urodynamics Mini-Fellowship

            Jan. 1993-Feb. 1993    Leicester General Hospital

                                                Leicester, England

                                                Urology Exchange Rotation

            July 1989-June 1991    University of Maryland Medical Systems

                                                Baltimore, Maryland

            May 2007-Present       Celsion Corporation

                                                Sub-Investigator

Post Marketing study using Prolieve for the Treatment of Benign Prostatic Hyperplasia (BPH)

            Nov. 2007-Present      Pfizer

                                                Principal Investigator

A Randomized, Double-Blinded, Placbo-Controlled study to evaluate the efficacy and safety of Fesoteridine as an "add-on" therapy in men with persistent overactive bladder symptoms under monotherapy of alpha blocker for lower urinary tract symptoms.

            May 2008-Present       Bioniche Therapeutics Limited

                                                Sub-Investigator

Open-Label, Multi-Center Study of the efficacy and safety of MCC in the treatment of patients with non-muscle invasive (Superficial) bladder cancer at high risk of progression and who are refractory to BCG.

American Urological Association

                                                American Medical Association

                                                American Lithotripsy Society

Levin, R.M., Crawford, E.D., "Carcinoma of the renal pelvis, ureter, and bladder" in Haskell, C.M. Cancer Treatment, Fourth edition, 1995.

Levin, R.M., Pfister, R.R., Koyle, M.A., Endoscopic Correction of Vesicoureteral Reflux:  A Cost Effective Approach.  Submitted for publication.

Levin, R.M. and Crawford, E.D., "Intracavernous Injections of PGE1:  Are We Immunosuppressing Cancer Patients," letter to the editor, Journal of Urology, 148:  1920, 1992. 

Levin, R.M., Pfister, R.R., Koyle, M.A., "The Sting Procedure:  The Children's Hospital Experience", Denver, Colorado; presented at the South Central Section of the American Urological Associations, Vancouver, British Columbia, August 1994.

Levin, R.M., Pfister, R.R., Koyle, M.A., "The Sting Procedure: The Children's Hospital Experience", Denver, Colorado; presented at the Royal Society of Medicine Section of Urology Winter Forum, Breckenridge, Colorado, February 1994.

                                                Cum Laude, University of Pennsylvania

                                                Pre-Medical Honor Society, University of Pennsylvania